PRTN3 and bronchopulmonary dysplasia: Both peak PR3 antigen expression (p = 0.03, Figure 6a) and peak thrombin activity (p = 0.03, Figure 6b) were significantly higher in BALF from BPD infants compared to No-BPD infants when measured in an in vitro assay.